Figure 4. Subgroup and sensitivity analyses of nonergot dopamine agonists evaluating mean change in International Restless Legs Syndrome Study Group scale.

CI=confidence interval; DA = dopamine agonists; ITT = intention to treat; NEDA = nonergot dopamine agonist; WMD = weighted mean difference.

Note: The dashed vertical line represents the combined treatment effect for the original analysis.